期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

癫痫患者生活质量及认知障碍的研究 被引量：3

Quality of Life and Cognitive Handicap in Epileptic
下载PDF
导出
摘要 通过正规用药,减少癫痫发作的程度和有效控制发作频率,提高癫痫患者生活质量及认知能力。 Regular medicaton can reduce the severity and frequency of epileptic attack , then the quality of life and cognitive handicap of the patients can be promoted.
作者 秦志伟 王星
机构地区 天津第三中心医院脑电图室
出处 《医学综述》 2006年第4期217-218,共2页 Medical Recapitulate
关键词 癫痫 生活质量 认知障碍 Epilepsy Auality of life Cognitive handicap
分类号 R742.1 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献17

  • 1王薇薇,陈静,吴逊.成年癫痫患者生活质量的研究[J].中华神经科杂志,2002,35(3):135-138. 被引量：35
  • 2Colling JA.Psychosocial well-being and epilepsy:an empirical study[J].Epilepsia,1990,31(4):418-426.
  • 3Raty L,Hamrin E,Soderfeldt B,et al.Quality of life in newlydebuted epilepsy.An empirical study[J].Acta Neurol Scand,1999,100(4):221-226.
  • 4Zhu D,Jin L, Xie G, et al. Qualitym of life and personality in adults with epilepsy[ J]. Epilepsia, 1998,39( 11 ) : 1208-1212.
  • 5Thompson P, Oxley J. Socioeconomic accompaniments of severe epilepsy[ J ]. Epilepsy, 1998,29( 1 ) : S9-S18.
  • 6Ahern GL, Herring AM, Tackenberg J, et al. The association of multiple personality and temporalimbic epilepsy [ J ]. Arch Neurol, 1993, 50(10) : 1020-1025.
  • 7Hayden M, Penna C, Buchanan N. Epilepsy: patient perceptions of their condition [ J ]. Seizure, 1992,1 ( 2 ) : 191-197.
  • 8Fraser RT, Clemmons D ,Trejo W, et al. Program evaluation in epilepsy rehabilitation [ J ]. Epilepsia, 1983,24 (7) : 734-736.
  • 9黑川,彻.癫痫患者的生活质量(QOL)[J].日本医学介绍,1998,19(9):411-413. 被引量：13
  • 10吴立文,任连坤,邵晓秋.重视癫痫对认知功能的影响[J].中华神经科杂志,2002,35(6):327-328. 被引量：18

二级参考文献52

  • 1Doose DR, Walker SA.Gisclon LG, et al.Single-dose pharmaco-kinetics of food on thebioavailability of topiramate, a novel antiepileptic drug.J Clin Pharmacol,1996, 36:884-891.
  • 2Degen PH, Flesch G, Cardot JM, et al.The influence of food on the disposition ofthe antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.BiopharmDrug Dispos, 1994, 15: 519-526.
  • 3Gidal BE, DeCerce J, Bockbrader HN, et al.Gabapentin bioavailability: effect ofdose and frequency of administration in adult patients with epilepsy.Epilepsy Res, 1998,31: 91-99.
  • 4Perucca E, Richens A.General principles: biotransformation.In: Levy RH, Mattson RH,Meldrum BS, eds.Antiepileptic drugs.4th ed.New York: Raven Press, 1995.31-50.
  • 5Patsalos PN.Antiepileptic drug pharmacogenetics.Ther Drug Monit, 2000, 22: 127-130.
  • 6Lindhout D.Pharmacogenetics and drug interactions role inantiepileptic-drug-induced teratogenesis.Neurology, 1992, 42: 43-47.
  • 7Anderon GD.A mechanistic approach to antiepileptic drug interactions.AnnPharmacother, 1998, 32: 554-563.
  • 8Schater SC.Oxcarbazepine: current status and clinical applications.Exp Opin InvestDrugs,1999, 8: 1103-1112.
  • 9Baruzzi A, Albani F, Riva R, et al.Oxcarbazepine: pharmacokinetic interaction andtheir clinical relevance.Epilepsia, 1994, 35 Suppl 3: S14-S19.
  • 10May TW, Rambeck B, Jurgens U.Influence of oxcarbazepine and methsuximide onlamotrigine concentrations in epileptic patients with and without valproic acidcomedication: results of a retrospective study.Ther Drug Monit, 1999, 21: 175-181.

共引文献152

同被引文献34

引证文献3

二级引证文献30

医学综述
2006年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部